27.01.2015 Views

Guidelines for second generation HIV surveillance - World Health ...

Guidelines for second generation HIV surveillance - World Health ...

Guidelines for second generation HIV surveillance - World Health ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Figure 4.2. Using <strong>HIV</strong> prevalence trends to predict trends in incidence<br />

Measured <strong>HIV</strong><br />

prevalence<br />

trends<br />

Interpret trends<br />

• Underlying changes in<br />

mortality (such as from<br />

wider ART access) or<br />

composition of population<br />

• Potential bias in measuring<br />

<strong>HIV</strong> prevalence trends<br />

Actual trends<br />

in new <strong>HIV</strong><br />

infections<br />

(incidence)<br />

Evaluating a National Surveillance System<br />

Confirm with other data<br />

• Consistent trends in other<br />

data (STI, behavioural,<br />

programmatic, others) that<br />

support the hypothesis that<br />

prevalence is changing<br />

Follow these steps when using prevalence data to understand how the epidemic is changing (Table 4.1).<br />

Table 4.1. Using <strong>HIV</strong> prevalence data to understand trends in incidence<br />

Step Action<br />

1 Understand the relationship between prevalence and incidence.<br />

2 Measure the prevalence, disaggregate by age groups, assess the potential selection bias.<br />

3 Look at other sources of data <strong>for</strong> evidence to support a change in trend of the incidence.<br />

Although the accuracy of <strong>HIV</strong> incidence tests has been the subject of considerable debate, these tests have<br />

been used widely and applied in several different ways. On an individual basis, the tests have been used<br />

to stage <strong>HIV</strong> infection clinically: how recently was the infection acquired, which treatment regimen to take,<br />

how to per<strong>for</strong>m contact tracing, and whether clinical trial enrolment is appropriate. From a public health<br />

perspective, the tests have been used to estimate the proportion of new, recently acquired <strong>HIV</strong> diagnosis<br />

in a population and to epidemiologically describe these cases. A third application is the use of these tests<br />

to estimate the rate of <strong>HIV</strong> incidence in populations. A new guide on how to use the <strong>HIV</strong> test <strong>for</strong> recent<br />

infections to estimate <strong>HIV</strong> incidence at population level is available at: http://www.who.int/diagnostics_<br />

laboratory/links/hiv_incidence_assay/en/<br />

4.1.2. Step 1: Understand the relationship between prevalence trends, incidence and mortality<br />

<strong>HIV</strong> prevalence over time is determined by:<br />

• the number of new infections (incidence)<br />

• the duration of infection<br />

• the mortality rate of those infected (deaths).<br />

The trend lines in Figure 4.3 show the natural course of an <strong>HIV</strong> epidemic. <strong>HIV</strong> prevalence does not decline<br />

until incidence declines and people with <strong>HIV</strong> begin to die.<br />

39

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!